Related Experiment Video
Updated: Jul 4, 2026

11:35
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Assistive device prescriptions in multiple sclerosis: a cross-sectional study of disability distribution
Rita Chiaramonte1,2, Michele Vecchio1,3, Paolo Di Benedetto4
1Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
Disability and Rehabilitation. Assistive Technology
|July 3, 2026
Summary
Assistive device needs in multiple sclerosis (MS) patients are primarily for mobility, with older individuals requiring more aids. Prescribing patterns vary by region and specialist, highlighting the need for tailored resource planning in MS care.
Area of Science:
- Neurology
- Rehabilitation Medicine
- Health Services Research
Background:
- Multiple sclerosis (MS) is a chronic, progressive neurological condition.
- MS leads to significant functional decline and increased need for assistive devices.
- Understanding assistive aid distribution is crucial for effective patient management.
Purpose of the Study:
- To analyze the distribution of assistive devices among multiple sclerosis patients.
- To correlate device needs with patient demographics and healthcare organization.
- To identify prescribing patterns and specialist roles in MS care.
Main Methods:
- Cross-sectional analysis of 600 prescriptions for 133 MS patients.
- Data collected from January to July 2025 in an Italian metropolitan urban area.
- Statistical associations assessed using Chi-squared tests (p < 0.05).
Main Results:
- Mobility aids (wheelchairs, attachments) constituted 48% of prescriptions.
- Orthopaedic footwear and orthoses accounted for 39.7%, emphasizing mobility needs.
- Age significantly influenced device type (p < 0.0001), with older patients needing more care.
- Physical medicine and rehabilitation specialists (63.2%) and neurologists (18.2%) were primary prescribers.
- Territorial variations in device types and specialties were observed (p < 0.0001).
Conclusions:
- Prescribing patterns for MS assistive devices are influenced by patient age, regional healthcare structures, and specialist involvement.
- Findings underscore the necessity for personalized resource planning and standardized, multidisciplinary care pathways.
- Ensuring equitable access and efficient resource allocation is vital for optimal MS patient outcomes.

